Little is known about the molecular pathway leading PAX2 to cause FSGS, but one hypothesis could be the regulation of WT1 by PAX2 [106], or a maladaptive response in case of PAX2-induced CAKUT with reduced nephron mass. This evidence concerns the gene WT1 and focal segmental glomerulosclerosis.